1. Home
  2. STVN vs CADE Comparison

STVN vs CADE Comparison

Compare STVN & CADE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • CADE
  • Stock Information
  • Founded
  • STVN 1949
  • CADE 1876
  • Country
  • STVN Italy
  • CADE United States
  • Employees
  • STVN N/A
  • CADE N/A
  • Industry
  • STVN Containers/Packaging
  • CADE Major Banks
  • Sector
  • STVN Consumer Discretionary
  • CADE Finance
  • Exchange
  • STVN Nasdaq
  • CADE Nasdaq
  • Market Cap
  • STVN 6.2B
  • CADE 6.9B
  • IPO Year
  • STVN 2021
  • CADE N/A
  • Fundamental
  • Price
  • STVN $23.67
  • CADE $35.72
  • Analyst Decision
  • STVN Buy
  • CADE Buy
  • Analyst Count
  • STVN 6
  • CADE 12
  • Target Price
  • STVN $27.50
  • CADE $36.83
  • AVG Volume (30 Days)
  • STVN 343.4K
  • CADE 981.6K
  • Earning Date
  • STVN 11-05-2024
  • CADE 01-27-2025
  • Dividend Yield
  • STVN 0.24%
  • CADE 2.79%
  • EPS Growth
  • STVN N/A
  • CADE 74.38
  • EPS
  • STVN 0.48
  • CADE 3.51
  • Revenue
  • STVN $1,220,254,294.00
  • CADE $1,271,175,000.00
  • Revenue This Year
  • STVN $3.01
  • CADE N/A
  • Revenue Next Year
  • STVN $7.16
  • CADE $5.91
  • P/E Ratio
  • STVN $49.11
  • CADE $10.21
  • Revenue Growth
  • STVN 3.53
  • CADE N/A
  • 52 Week Low
  • STVN $16.56
  • CADE $24.99
  • 52 Week High
  • STVN $34.73
  • CADE $40.20
  • Technical
  • Relative Strength Index (RSI)
  • STVN 77.49
  • CADE 40.64
  • Support Level
  • STVN $19.25
  • CADE $35.92
  • Resistance Level
  • STVN $24.90
  • CADE $36.67
  • Average True Range (ATR)
  • STVN 1.02
  • CADE 0.78
  • MACD
  • STVN 0.38
  • CADE -0.37
  • Stochastic Oscillator
  • STVN 78.23
  • CADE 4.93

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About CADE Cadence Bank

Cadence Bank is a bank based in the United States. The operating segments are Corporate Banking segment focuses on C&I, business banking, and commercial real estate lending to clients in the geographic footprint, Community Banking segment provides a broad range of banking services through the branch network to serve the needs of community businesses and individual consumers in the geographic footprint, Mortgage segment includes mortgage banking activities of originating mortgage loans, selling mortgage loans in the secondary market and servicing the mortgage loans, Banking Services segment offers individuals, businesses, governmental institutions, and non-profit entities a widerange of solutions to help protect, grow, and transfer wealth, General Corporate and Other segment.

Share on Social Networks: